FIELD: pharmacology.
SUBSTANCE: invention relates to a dipeptide prodrug of general formula (I)
,
which can be used to treat and/or prevent cardiovascular diseases.
EFFECT: increased application effeciency.
3 cl, 4 tbl, 7 ex
| Title | Year | Author | Number |
|---|---|---|---|
| DIPEPTIDE PRODRUGS AND USE THEREOF | 2008 |
|
RU2486183C9 |
| REPLACED DIHYDROPYRAZOLONES AS INHIBITORS OF HIF-PROLYL-4-HYDROXYLASE | 2009 |
|
RU2509080C9 |
| SUBSTITUTED DIHYDROPYRAZOLONES FOR TREATING CARDIOVASCULAR AND HEMATOLOGIC DISEASES, USE THEREOF, DRUG AND METHOD OF TREATING AND/OR PREVENTING | 2012 |
|
RU2611012C2 |
| SUBSTITUTED 4-ARYL-1,4-DIHYDRO-1,6-NAPHTHYRIDINE AMIDES AND USE THEREOF | 2008 |
|
RU2470932C9 |
| AMINOACYL DERIVATIVES AS PRODRUGS AND PREPARATIONS FOR TREATING THROMBOEMBOLIC DISEASES | 2007 |
|
RU2456283C9 |
| PIPERIDINYLPYRAZOLOPYRIMIDINONES AND USE THEREOF | 2015 |
|
RU2713937C2 |
| SUBSTITUTED OXOPYRIDINE DERIVATIVE | 2019 |
|
RU2792645C2 |
| NEW CYCLOPENTA[B]BENZOFURANYL DERIVATIVES AND APPLICATION THEREOF | 2005 |
|
RU2415847C9 |
| COMBINATION OF MUSCARINE RECEPTOR ANTAGONIST AND BETA-2-ADRENORECEPTOR AGONIST | 2008 |
|
RU2460527C2 |
| DERIVANTS OF BICYCLO[2, 2, 1] HEPT-7-YLAMINE AND THEIR APPLICATIONS | 2006 |
|
RU2442771C2 |
Authors
Dates
2017-08-30—Published
2013-03-13—Filed